Skip to content

Study on the Efficacy and Safety of Qizheng Xiaotong Plaster Combined with Sodium Hyaluronate Knee Joint Injection in the Treatment of Knee Osteoarthritis Patients

Study on the Efficacy and Safety of Qizheng Xiaotong Plaster Combined with Sodium Hyaluronate Knee Joint Injection in the Treatment of Knee Osteoarthritis Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084555
Enrollment
Unknown
Registered
2024-05-20
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Sodium Hyaluronate group:Sodium Hyaluronate Knee Joint Injection
Qizheng Xiaotong Plaster Combined with Sodium Hyaluronate group:Qizheng Xiaotong Plaster Combined with Sodium Hyaluronate Knee Joint Injection

Sponsors

Hengdian Wenrong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with knee joint pain caused by knee osteoarthritis (KOA); 2.Patients with Kellgren-Lawrence radiographic grade of I-III; 3.Patients who are not suitable or unwilling to undergo surgical treatment; 4.Stable condition and suitable for follow-up; 5.Patients who can understand and comply with the clinical protocol requirements, voluntarily participate in the clinical trial, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with knee arthritis caused by other immune system diseases, such as rheumatic diseases, gout, etc.; 2.Patients with acute synovitis and acute trauma; 3.Patients with a known allergy to Qizhengxiaotong Plaster; 4.Patients with mental illness or unable to cooperate with the investigation; 5.Patients who have received other effective treatment regimens recommended by other clinical guidelines, such as oral nonsteroidal drugs, local injection of steroids, acupuncture, etc. within the past month; 6.Patients who, in the opinion of the researchers, may pose a risk to the safety of the subjects, affect the assessment of the researchers, or have poor compliance with the protocol.

Design outcomes

Primary

MeasureTime frame
Visual analogue pain score;

Secondary

MeasureTime frame
WOMAC;

Countries

China

Contacts

Public ContactKangxiang Guo

Hengdian Wenrong Hospital

1247644060@qq.com+86 139 6790 4746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026